These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4371532)

  • 1. Synergy of 9-beta-D-arabinofuranosyladenine and human interferon against Herpes simplex virus, type 1.
    Lerner AM; Bailey EJ
    J Infect Dis; 1974 Nov; 130(5):549-52. PubMed ID: 4371532
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential sensitivity of herpes simplex virus types 1 and 2 to human interferon: antiviral effects of interferon plus 9-beta-D-arabinofuranosyladenine.
    Lerner AM; Bailey EJ
    J Infect Dis; 1976 Oct; 134(4):400-4. PubMed ID: 185303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity of 2,3-dihydro-1H-imidazo[1,2-b]pyrazole in herpes simplex virus type 1-infected mammalian cells.
    Pelling JC; Shipman C
    Biochem Pharmacol; 1976 Nov; 25(21):2377-82. PubMed ID: 187202
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined antiviral effect of interferon and acyclovir on herpes simplex virus types 1 and 2.
    Stanwick TL; Schinazi RF; Campbell DE; Nahmias AJ
    Antimicrob Agents Chemother; 1981 Apr; 19(4):672-4. PubMed ID: 6166248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity of 9-beta-D-arabinofuranosyladenine (ara-A) against Gross murine leukemia virus in vitro.
    Shannon WM; Westbrook L; Schabel FM
    Proc Soc Exp Biol Med; 1974 Feb; 145(2):542-5. PubMed ID: 4855983
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combined action of nucleosides and alpha-interferon in inhibiting the reproduction of the herpes simplex type-II virus].
    Temicheva EV; Malinovskaia VV; Manakhova LS; Mironova LL; Galegov GA
    Biull Eksp Biol Med; 1987 Oct; 104(10):490-2. PubMed ID: 2823929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent synergistic inhibition of herpes simplex virus-2 by 9-[(1, 3-dihydroxy-2-propoxy)methyl]guanine in combination with recombinant interferons.
    Eppstein DA; Marsh YV
    Biochem Biophys Res Commun; 1984 Apr; 120(1):66-73. PubMed ID: 6201172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sensitivity of herpes simplex virus to antiviral and other several drugs].
    Kaneko M
    Nippon Ganka Gakkai Zasshi; 1972 Jul; 76(7):399-403. PubMed ID: 4343906
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiviral chemotherapy.
    Luby JP; Johnson MT; Jones SR
    Annu Rev Med; 1974; 25():251-67. PubMed ID: 4363207
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in synchronized suspension cultures.
    Shipman C; Smith SH; Carlson RH; Drach JC
    Antimicrob Agents Chemother; 1976 Jan; 9(1):120-7. PubMed ID: 176927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
    Champney KJ; Lauter CB; Bailey EJ; Lerner AM
    J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity of certain substituted purine and pyrimidine nucleosides.
    Diwan AR; Robins RK; Prusoff WH
    Experientia; 1969 Jan; 25(1):98-100. PubMed ID: 4304043
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro system for studying the efficacy of antiviral agents in preventing the reactivation of latent herpes simplex virus.
    Wohlenberg C; Openshaw H; Notkins AL
    Antimicrob Agents Chemother; 1979 Apr; 15(4):625-7. PubMed ID: 223499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of four antiviral agents in the treatment of herpes simplex encephalitis in a rat model.
    Marks MI
    J Infect Dis; 1975 Jan; 131(1):11-6. PubMed ID: 162922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory and lethal concentrations of 9-beta-D-arabinofuranosyladenine and its hypoxanthine-derivative versus herpes simplex virus, type 1.
    Williams BB; Bailey EJ; Lerner AM
    J Lab Clin Med; 1977 Apr; 89(4):687-91. PubMed ID: 191546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleic acids. 14. Synthesis and antiviral activity of some 5'-esters of 9-beta-D-arabinofuranosyladenine (ara-A).
    Renis HE; Gish DT; Court BA; Eidson EE; Wechter WJ
    J Med Chem; 1973 Jul; 16(7):754-7. PubMed ID: 4353601
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative studies on the inhibitory effects of interferon on various strains of herpes simplex viruses in vitro.
    Imanishi J; Matsubara M; Kishida T; Ozaki Y; Kurimura T
    Biken J; 1980 Sep; 23(3):107-11. PubMed ID: 6161604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of flavones and flavonols against herpes simplex virus type 1 in cell culture. Comparison with the antiviral activity of propolis.
    Amoros M; Simões CM; Girre L; Sauvager F; Cormier M
    J Nat Prod; 1992 Dec; 55(12):1732-40. PubMed ID: 1338212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of viruses.
    Goz B; Prusoff WH
    Annu Rev Pharmacol; 1970; 10():143-70. PubMed ID: 4986558
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects on herpes simplex virus type 1 of combined use of interferon-beta and anti-herpetic agents in vitro.
    Naito T; Shiota H; Nitta K; Mimura Y
    Jpn J Ophthalmol; 1990; 34(1):15-21. PubMed ID: 2163462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.